129
Views
4
CrossRef citations to date
0
Altmetric
Commentary

Immune-modulatory effects of bortezomib in GVHD

Pages 853-854 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Camilla Stapnes, Bjørn Tore Gjertsen, Håkon Reikvam & Øystein Bruserud. (2009) Targeted therapy in acute myeloid leukaemia: current status and future directions. Expert Opinion on Investigational Drugs 18:4, pages 433-455.
Read now

Articles from other publishers (3)

David Tung, Peter H. Cheung, Pali Kaur, Oded Foreman, Anoop Kavirayani, Heather S. Hain & Saurabh Saha. (2011) Anti-Inflammatory and Immunomodulatory Effects of Bortezomib in Various in vivo Models. Pharmacology 88:1-2, pages 100-113.
Crossref
Jung-Sik Kim, Jae-Il Lee, Jin-Young Shin, Su-Young Kim, Jun-Seop Shin, Jong-Hyung Lim, Hyoung-Soo Cho, Il-Hee Yoon, Ki-Hyun Kim, Sang-Joon Kim & Chung-Gyu Park. (2009) Bortezomib Can Suppress Activation of Rapamycin-Resistant Memory T Cells Without Affecting Regulatory T-Cell Viability in Non-Human Primates. Transplantation 88:12, pages 1349-1359.
Crossref
John Koreth, Edwin P. Alyea, William J. Murphy & Lisbeth A. Welniak. (2009) Proteasome Inhibition and Allogeneic Hematopoietic Stem Cell Transplantation: A Review. Biology of Blood and Marrow Transplantation 15:12, pages 1502-1512.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.